SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $58,000 | -88.3% | 10,015 | -84.9% | 0.00% | -100.0% |
| Q4 2021 | $497,000 | -52.9% | 66,200 | -43.4% | 0.00% | -75.0% |
| Q3 2021 | $1,055,000 | -28.9% | 117,000 | -5.6% | 0.00% | -33.3% |
| Q2 2021 | $1,483,000 | +856.8% | 123,900 | +899.2% | 0.01% | +500.0% |
| Q1 2021 | $155,000 | -53.9% | 12,400 | -42.3% | 0.00% | 0.0% |
| Q4 2020 | $336,000 | +10.9% | 21,482 | -23.6% | 0.00% | -66.7% |
| Q2 2019 | $303,000 | +53.8% | 28,100 | +36.4% | 0.00% | +50.0% |
| Q1 2019 | $197,000 | -40.8% | 20,600 | +5.1% | 0.00% | 0.0% |
| Q3 2018 | $333,000 | -2.3% | 19,600 | +9.2% | 0.00% | -33.3% |
| Q1 2018 | $341,000 | – | 17,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |